| BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma P Bandopadhayay, G Bergthold, B Nguyen, S Schubert, S Gholamin, ... Clinical Cancer Research 20 (4), 912-925, 2014 | 380 | 2014 |
| Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors S Gholamin, SS Mitra, AH Feroze, J Liu, SA Kahn, M Zhang, R Esparza, ... Science translational medicine 9 (381), eaaf2968, 2017 | 354 | 2017 |
| Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo M Zhang, G Hutter, SA Kahn, TD Azad, S Gholamin, CY Xu, J Liu, ... PloS one 11 (4), e0153550, 2016 | 332 | 2016 |
| Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition Y Tang, S Gholamin, S Schubert, MI Willardson, A Lee, P Bandopadhayay, ... Nature medicine 20 (7), 732-740, 2014 | 323 | 2014 |
| Immune evasion strategies of glioblastoma SM Razavi, KE Lee, BE Jin, PS Aujla, S Gholamin, G Li Frontiers in surgery 3, 11, 2016 | 251 | 2016 |
| Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma G Hutter, J Theruvath, CM Graef, M Zhang, MK Schoen, EM Manz, ... Proceedings of the National Academy of Sciences 116 (3), 997-1006, 2019 | 210 | 2019 |
| Gpr124 is essential for blood–brain barrier integrity in central nervous system disease J Chang, MR Mancuso, C Maier, X Liang, K Yuki, LU Yang, JW Kwong, ... Nature medicine 23 (4), 450-460, 2017 | 199 | 2017 |
| MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma H Mirzaei, S Gholamin, S Shahidsales, A Sahebkar, MR Jaafari, ... European journal of cancer 53, 25-32, 2016 | 185 | 2016 |
| GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma S Gholamin, H Mirzaei, SM Razavi, SM Hassanian, L Saadatpour, ... Journal of cellular physiology 233 (2), 866-879, 2018 | 111 | 2018 |
| Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia SM Razavi, S Gholamin, A Eskandari, N Mohsenian, A Ghorbanihaghjo, ... Journal of Medicinal Food 16 (3), 255-258, 2013 | 104 | 2013 |
| The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment S Gholamin, A Pasdar, M Sadegh Khorrami, H Mirzaei, H Reza Mirzaei, ... Current pharmaceutical design 22 (3), 397-403, 2016 | 96 | 2016 |
| IFNγ is critical for CAR T cell–mediated myeloid activation and induction of endogenous immunity D Alizadeh, RA Wong, S Gholamin, M Maker, M Aftabizadeh, X Yang, ... Cancer discovery 11 (9), 2248-2265, 2021 | 88 | 2021 |
| Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma T Purzner, J Purzner, T Buckstaff, G Cozza, S Gholamin, JM Rusert, ... Science signaling 11 (547), eaau5147, 2018 | 70 | 2018 |
| Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway RT Nitta, S Gholamin, AH Feroze, M Agarwal, SH Cheshier, SS Mitra, G Li Oncogene 34 (28), 3688-3699, 2015 | 60 | 2015 |
| Medical versus medical and surgical treatment for brucella endocarditis M Keshtkar-Jahromi, SM Razavi, S Gholamin, M Keshtkar-Jahromi, ... The Annals of thoracic surgery 94 (6), 2141-2146, 2012 | 60 | 2012 |
| The anti‐hypertensive drug prazosin inhibits glioblastoma growth via the PKC δ‐dependent inhibition of the AKT pathway S Assad Kahn, SL Costa, S Gholamin, RT Nitta, LG Dubois, M Fève, ... EMBO molecular medicine 8 (5), 511-526, 2016 | 50 | 2016 |
| Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma SA Kahn, X Wang, RT Nitta, S Gholamin, J Theruvath, G Hutter, TD Azad, ... Nature communications 9 (1), 4121, 2018 | 48 | 2018 |
| Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma S Gholamin, OA Youssef, M Rafat, R Esparza, S Kahn, M Shahin, ... Innate immunity 26 (2), 130-137, 2020 | 35 | 2020 |
| Comparing peripheral blood mononuclear cell DNA and circulating plasma viral RNA pol genotypes of subtype C HIV-1 L Banks, S Gholamin, E White, L Zijenah, DA Katzenstein Journal of AIDS & clinical research 3 (2), 141, 2012 | 32 | 2012 |
| Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: rationale and progress S Gholamin, H Fiuji, M Maftouh, R Mirhafez, F Homaei Shandiz, A Avan Current drug targets 15 (14), 1302-1311, 2014 | 31 | 2014 |
Suzana Assad KahnPostdoctoral Scholar, Stanford UniversityVerified email at stanford.edu
